Ordinary Index Rebalancing in the Julius Baer Next Generation Genomics Index | April 2021

In the ordinary rebalance the following composition will be implemented effective open 08.04.2021:

AMGEN INC
ASTRAZENECA PLC
BB BIOTECH AG
BEIGENE LTD-ADR
BIONTECH SE
BRISTOL-MYERS SQUIBB CO
CRISPR THERAPEUTICS AG
GILEAD SCIENCES INC
ILLUMINA INC
INNOVENT BIOLOGICS INC
IQVIA HOLDINGS INC
LONZA GROUP AG
MERCK KGAA
MODERNA INC
NATERA INC
REGENERON PHARMACEUTICALS
ROCHE HOLDING AG
TAKEDA PHARMACEUTICAL
THERMO FISHER SCIENTIFIC INC
WUXI BIOLOGICS CAYMAN INC